ClinicalTrials.gov
public full text
Public Domain
Efficacy and Safety of the Association Drugs in Patients With Allergic Dermatitis
Considering the pathogenesis of several allergic skin diseases to be investigated in this study as well as the pharmacodynamic mechanisms of the association of dexamethasone and clemastine fumarate, it is believed that the components of topical medication may act synergistically in the reduction of signs and symptoms of the diseases in question. Therefore it is expected that the association promotes results significantly superior to dexamethasone alone.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Olea Europaea Pollen#847631
- Management of Pruritus With Xyzal in Atopic Dermatitis#811466
- Efficacy/Safety Study to Explore a New Topical Formulation in Atopic Dermatitis#1007571
- Randomized Study to Compare the Bioequivalence of Two Fluticasone Propionate 0.05% Topical Creams#1172089
- A Study to Evaluate Changes in Nasal Airflow of Loratadine/Pseudoephedrine Tablet and Fluticasone Propionate Nasal Spray in Subjects Following Allergen Exposure#1096074
Record · ID 834432
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive